NATDECITA 50MG INJECTION

Form: Injection

Pack Size: 1 VIAL

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹2228.38

NATCO PHARMA LTD (ONCOLOGY DIV): Natdecita 50MG Injection, 1 vial, salt decitabine 50mg. NPPA has revised its MRP from Rs 4,344.38 to Rs 2,228.38 (49% lower) with effect from 09-11-2026; trade rate Rs 1,697.81. Group: hypomethylating agent (chemotherapy). Same salt is also supplied by Sun Pharma. Handling/counselling: IV infusion in hospital or day-care; cytotoxic: handle and dispose of as hazardous waste. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.